News | Computer-Aided Detection Software | March 15, 2017

Parascript Exhibiting at NCoBC Conference 2017

Company will demonstrate AccuDetect CAD for Mammography

Parascript, AccuDetect CAD for Mammography, computer-aided detection, NCoBC 2017

March 15, 2017 — Parascript will exhibit at the National Consortium of Breast Centers (NCoBC) 27th Conference, March 11-17, 2017, in Las Vegas, where the company will provide a demo of its AccuDetect Computer-Aided Detection (CAD) for Mammography.

Established in 1985, the National Consortium of Breast Centers is an interdisciplinary organization created to ensure quality patient care at breast centers through education, certification and interdisciplinary communication. The consortium is dedicated to improving the outcomes of breast care patients and assisting healthcare providers. In its 27th year, the conference brings together breast health professionals, technology experts and equipment specialists as well as drug and service providers to demonstrate the latest technology and breast care options available.

At NCoBC, Parascript will demonstrate AccuDetect CAD, which uses multiple independent cancer detection algorithms and a patented voting methodology to combine its findings. Comparing the results of the multiple image recognition processes allows for improved sensitivity and reduced false-positive rates, resulting in precise CAD markings for areas of interest.

Hospitals throughout the country have commented on AccuDetect’s rapid processing capabilities, according to Parascript. The company said AccuDetect CAD processes breast images significantly faster than the top competition with a processing time of just 11 seconds per image, and 45 seconds per four-view study. The average CAD system takes 30 seconds or more to process a single image.

“Having Parascript software sets us apart from what is going on around us. It lets people know that we are serious about taking care of their health and taking care of their families,” said Ronnie Dillion, director of radiology at the Ashley County Medical Center, Crossett, Ark.

For more information: www.parascript.com

Related Content

Therapixel Wins the Digital Mammography Challenge
News | Mammography | June 23, 2017
June 23, 2017 — French radiology technology company Therapixel was recently named the winner of the Digital Mammograp
ClearRead CT Nearing 50 Installations Milestone
News | Computed Tomography (CT) | June 22, 2017
June 22, 2017 — Riverain Technologies announced that it is now processing data from nearly 50...
MRI Plus Mammography Improves Detection of New Breast Cancer After Surgery
News | Breast Imaging | June 22, 2017
A new article published by JAMA Oncology compares outcomes for combined mammography and magnetic resonance imaging (MRI...
Combined Optical and Molecular Imaging Could Guide Breast-Conserving Surgery

WLE specimen from a patient with a grade 3, ER-/HER2-, no special type (NST) carcinoma. (A) Cerenkov image; (B) Grey-scale photographic image overlaid with Cerenkov signal. An increased signal from the tumor is visible (white arrows); mean radiance is 871 ± 131 photons/s/cm2/sr, mean TBR is 3.22. Both surgeons measured the posterior margin (outlined in blue) as 2 mm (small arrow); a cavity shaving would have been performed if the image had been available intraoperatively. The medial margin (outlined in green) measured >5 mm by both surgeons. Pathology ink prevented assessing the lateral margin; a phosphorescent signal is visible (open arrows). (C) Specimen radiography image. The absence of one surgical clip to mark the anterior margin, and the odd position of the superior margin clip (white arrow) prevented reliable margin assessment. (D) Combined histopathology image from two adjacent pathology slides on which the posterior margin (bottom of image) and part of the primary tumor are visible (open arrows). The distance from the posterior margin measured 3 mm microscopically (double arrow). The medial margin is > 5 mm (not present in image). Credit: A. D. Purushotham, M.D., King’s College London, UK

News | Nuclear Imaging | June 20, 2017
June 20, 2017 — Breast-conserving surgery (BCS) is the primary treatment for early-stage...
ABS Clinical Director Alexandra Valencia, M.D.,  and consultant radiographer Gillian Clark using Insignia.

ABS Clinical Director Alexandra Valencia, M.D.,  and consultant radiographer Gillian Clark using Insignia.

News | Breast Imaging | June 12, 2017
ABS, one of the largest breast departments in the country, first signed with Insignia in 2010, and have confirmed a...
mammogram

Photo courtesy of Barco

News | Mammography | June 08, 2017
An analysis of breast cancer data revealed that many small breast cancers have an excellent prognosis because they are...
OCM images

These are sample OCM images (first row) and corresponding histology images (second row) of human breast tissue. The ground truth labels for the tissue type of these images are: (a) carcinoma, (b) lobule, (c) stroma, (d) adipose. Image courtesy of Sunhua Wan, Hsiang-Chieh Lee, Xiaolei Huang, Ting Xu, Tao Xu, Xianxu Zeng, Zhan Zhang, Yuri Sheikine, James L. Connolly, James G. Fujimoto, Chao Zhou

News | Clinical Study | June 07, 2017
According to a recent study, one in four women with breast cancer who opt for a breast-saving lumpectomy will need a...
News | Mammography | June 07, 2017
Hologic, Inc. announced that the Genius 3D Mammography exam is now the only mammogram that is FDA-approved as superior...
Feature | Women's Health | June 06, 2017 | By David A. Strahle, M.D.
Editor’s note: In this article, David A. Strahle, M.D., candidly shares how and why he and his team became involved...
breast tomosynthesis
News | Breast Imaging | June 06, 2017
Researchers at two leading U.S. breast centers recently completed a study which explored whether women attending...
Overlay Init